W 140 (Lansoprazole delayed release 15 mg)
Pill imprint W 140 has been identified as Lansoprazole delayed release 15 mg.
Lansoprazole is used in the treatment of gerd; barrett's esophagus; stomach ulcer; erosive esophagitis; nsaid-induced ulcer prophylaxis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 15 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for W 140 (Lansoprazole delayed release 15 mg)
Lansoprazole delayed release is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...